Brandinium

Trademark search for:

IMARX THERAPEUTICS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2007-05-21 — Application filed
  • 2007-05-24 — Application filed
  • 2007-05-25 — Notice of design search code mailed
  • 2007-08-29 — Final disposition recorded
  • 2007-08-29 — Final disposition recorded
  • 2007-08-29 — Assigned to examiner
  • 2007-08-29 — Final disposition recorded
  • 2007-11-07 — Teas/email correspondence entered
  • 2007-11-07 — Office action issued
  • 2007-11-07 — Correspondence received in law office
  • 2007-11-21 — Final disposition recorded
  • 2007-11-21 — Final disposition recorded
  • 2007-11-21 — Final disposition recorded
  • 2008-02-25 — Teas/email correspondence entered
  • 2008-02-25 — Office action issued
  • 2008-02-25 — Correspondence received in law office
  • 2008-03-10 — Approved for pub - principal register
  • 2008-03-25 — Assigned to lie
  • 2008-03-25 — Law office publication review completed
  • 2008-04-09 — Notice of publication
  • 2008-04-29 — Published for opposition
  • 2008-05-09 — Teas change of correspondence received
  • 2008-07-22 — Noa mailed - sou required from applicant
  • 2009-02-23 — Application abandoned
  • 2009-02-23 — Application abandoned
  • 2009-02-23 — Final status recorded

Owner Information

ImaRx Therapeutics, Inc.
Tucson , AZ
ImaRx Therapeutics, Inc.
Tucson , AZ

Correspondent

Dale F. Regelman Quarles & Brady LLP
One South Church Avenue, Ste. 1700
Tucson, AZ 85701-1621
UNITED STATES

Filing Details

Filing Date:
2007-05-21
Status Date:
2009-02-23
Category:
Pharmaceuticals
Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.